Refine Results
- view as grid
- view as list
Analysis Examines the Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common services on their websites. A second…
News Release Read More
Price Transparency and Price Variation in U.S. Health Services
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.
Issue Brief Read More
Trends in Overall and Non-COVID-19 Hospital Admissions
This brief analyzes hospital admission data to show how the number of admissions changed in 2020 due to the COVID-19 pandemic.
Issue Brief Read More
Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: More Time to Repay
This brief provides an overview and status update of the Medicare accelerated and advance payment program, which provided $100 billion in loans to Medicare providers in the spring of 2020 to compensate for revenue shortfalls due to the coronavirus pandemic. The brief describes who got the funds, and how these loans are distinct from other funds that providers received, which do not have to be repaid.
Issue Brief Read More
The Cost of Inpatient and Outpatient Care Drives High Health Spending in the U.S. Relative to Other Countries, New Analysis Finds
A new KFF issue brief compares the main drivers of health spending in the United States and other large, wealthy countries, and finds that the cost of inpatient and outpatient care – much more so than prescription drugs or administrative costs – drives high per capita health spending in the U.S.…
News Release Read More
Drugs Aren’t the Reason the U.S. Spends So Much on Health Care
Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.
Perspective Read More
Analysis Compares President Trump and Democratic Nominee Biden on COVID-19
Few issues are likely to matter as much to voters in November’s presidential election as President Trump’s response to the COVID-19 pandemic and resulting economic crisis, which have left almost 200,000 Americans dead and prompted job layoffs and furloughs affecting tens of millions of Americans. A new election brief compares…
News Release Read More
Comparing Trump and Biden on COVID-19
This issue brief compares President Trump and Democratic nominee Joe Biden on their records, actions and proposals related to the COVID-19 pandemic. It includes a general overview of their respective approaches, followed by a detailed side-by-side.
Issue Brief Read More
The Veterans Health Administration’s Role During the COVID-19 Response
A new issue brief examines the role of the Veterans Health Administration (VHA) during the coronavirus pandemic, and public health emergencies more broadly. The analysis finds that the VHA has provided assistance to 46 states and D.C., including treating over 270 non-veteran patients with coronavirus.
Issue Brief Read More